Circle of Life is a software product company that uses advanced machine learning to generate a highly accurate personalized predicted culture report instantly for a patient with a suspected infection through its flagship product ZEVAC thereby allowing for the right drug to be provided to the right patient at the right time. ZEVAC also automates NHSN reporting, alerts, prescription compliance, drug bug trend changes etc. to significantly ease manual tasks and workload of AMS team members.

We are a research oriented organisation and have several members from academia and research working with us and guiding the team to deliver our cutting edge solution. We have on going research projects with some of the top medical schools in the country in various stages. Several papers have already been generated by the team and have been submitted to market leading journals like Lancet, PLOS and Nature. In the coming months we plan to conduct multi centric research studies across countries like US, ...
Circle of Life is a software product company that uses advanced machine learning to generate a highly accurate personalized predicted culture report instantly for a patient with a suspected infection through its flagship product ZEVAC thereby allowing for the right drug to be provided to the right patient at the right time. ZEVAC also automates NHSN reporting, alerts, prescription compliance, drug bug trend changes etc. to significantly ease manual tasks and workload of AMS team members.

We are a research oriented organisation and have several members from academia and research working with us and guiding the team to deliver our cutting edge solution. We have on going research projects with some of the top medical schools in the country in various stages. Several papers have already been generated by the team and have been submitted to market leading journals like Lancet, PLOS and Nature. In the coming months we plan to conduct multi centric research studies across countries like US, Singapore and Netherlands to establish the global applicability of our product.

With our highly accurate algorithms we are able to predict the culture results in advance with 85% accuracy while most doctors are able to get it right only 60% of the times as per published reports. This high level of accuracy reinforces our singular focus on providing personalized, precision medicine to the patient against infectious diseases which still form a big part of the disease burden in not just our country but globally.

While the infection control and AMS teams in the hospitals are putting in their best efforts to tackle the problem, the high degree of time and effort required for mundane tasks makes their effectiveness redundant. By introducing AI capability into our simple to use software we are able to free a significant amount of time and energy of these teams that can then be directed towards more worthwhile tasks and is a big value add to the healthcare system. Also our data and technology stacks are designed with global standards and interoperability in mind that makes the product easily deployable in any geography/ clinical setup.
More information

Employees

Vaibhav@Vs677267 Singh
Admin
Vaibhav@Vs677267 Singh CEO Double masters with 20+ years experience in private equity, consulting, M&A and advisory having worked in ~30 countries
Dr. Seema Singh
Admin
Dr. Seema Singh